Figure 3.
(a) Association between PDLIM5 expression in the heart and left ventricular ejection fraction (LVEF) in the patient with the PDLIM5 frameshift mutation and eight control dilated cardiomyopathy (DCM) patients. (b) Expression of PDLIM5 mRNA in the cardiac biopsy of the patient with the PDLIM5 frameshift mutation and two DCM control groups with high and low LVEF, respectively. Statistical stars on data figures represent ***p ≤ .001